Market share of the leading cholesterol-lowering supplements in Italy 2018

Published by
Juliette Gagliardi,
Jun 19, 2022
As of January 2018, Armolipid Plus was dominating the market of cholesterol-lowering supplements in Italy. This supplement, in fact, accounted for 20 percent of the whole market. The second in this special ranking, Ezimega Plus, represented for just five percent of the market.

Market share of the leading cholesterol-lowering supplements in Italy as of January 2018*

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

March 2018

Region

Italy

Survey time period

January 2018

Citation formats
Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$69 USD $49 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you

Overview

5

Risk factors and behaviors

8

Chronic diseases

8

Cancers

5

Mental health

5

Diesease-related deaths

5

Further related statistics

18

Further Content: You might find this interesting as well

Statistics

Topics

State of health in ItalyDigital healthcare in ItalyHealth and food supplements market in ItalySelf-medication in ItalyPharmaceutical market in Italy
Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Learn more about how Statista can support your business.
Menu